Bruce Ponder
Corporate Officer/Principal chez University of Cambridge
Profil
Bruce Ponder is currently a Professor of Oncology at the University of Cambridge.
Prior to this, he worked as a Director at The Bioscience Investment Trust Plc from 2000 to 2012.
He also served as a Trustee at Cancer Research UK.
Postes actifs de Bruce Ponder
| Sociétés | Poste | Début |
|---|---|---|
| University of Cambridge | Corporate Officer/Principal | - |
Anciens postes connus de Bruce Ponder
| Sociétés | Poste | Fin |
|---|---|---|
The Bioscience Investment Trust Plc
 The Bioscience Investment Trust Plc Financial ConglomeratesFinance The Bioscience Investment Trust Plc (formerly 3i Bioscience Investment Trust) provides financial and investment services. It aims to achieve long-term capital growth by investing in life science and healthcare companies in which value growth is expected to occur through the development or application of technology. The company invests in companies including Amgen, Inc., Gilead Science, Inc., Align Technology, Inc., Acambis Plc, Shire Pharmaceuticals Group Plc, Celgene Corp., Protein Design Labs, Inc., Alizyme Plc, Gyrus Group Plc and Advanced Neuromudulation Systems, Inc. Bioscience Investment Trust Plc is headquartered in London, UK. | Directeur/Membre du Conseil | 07/03/2012 |
Cancer Research UK
 Cancer Research UK Miscellaneous Commercial ServicesCommercial Services Cancer Research UK provides cancer research services. It supports and undertakes research on the biology and causes of cancer and develops anti-cancer drugs. The firm also provides general information about cancer and types of treatments and funds projects that help patients cope with the side effects of cancer and its treatment. Its institute also operates an online portal CancerHelp UK that provides patient information. The company was founded in 2001 and is headquartered in London, the United Kingdom. | Directeur/Membre du Conseil | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
The Bioscience Investment Trust Plc
The Bioscience Investment Trust Plc Financial ConglomeratesFinance The Bioscience Investment Trust Plc (formerly 3i Bioscience Investment Trust) provides financial and investment services. It aims to achieve long-term capital growth by investing in life science and healthcare companies in which value growth is expected to occur through the development or application of technology. The company invests in companies including Amgen, Inc., Gilead Science, Inc., Align Technology, Inc., Acambis Plc, Shire Pharmaceuticals Group Plc, Celgene Corp., Protein Design Labs, Inc., Alizyme Plc, Gyrus Group Plc and Advanced Neuromudulation Systems, Inc. Bioscience Investment Trust Plc is headquartered in London, UK. | Finance |
Cancer Research UK
Cancer Research UK Miscellaneous Commercial ServicesCommercial Services Cancer Research UK provides cancer research services. It supports and undertakes research on the biology and causes of cancer and develops anti-cancer drugs. The firm also provides general information about cancer and types of treatments and funds projects that help patients cope with the side effects of cancer and its treatment. Its institute also operates an online portal CancerHelp UK that provides patient information. The company was founded in 2001 and is headquartered in London, the United Kingdom. | Commercial Services |
